Shares of T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0006. T2 Biosystems shares last traded at $0.0006, with a volume of 4,794 shares.
T2 Biosystems Trading Up 266.7%
The firm has a market cap of $46,294.60, a price-to-earnings ratio of 0.00 and a beta of 0.88.
T2 Biosystems Company Profile
T2 Biosystems, Inc is a commercial‐stage diagnostics company focused on developing and marketing innovative, rapid diagnostic products designed to improve patient outcomes and reduce healthcare costs. The company’s proprietary T2 Magnetic Resonance (T2MR) technology enables direct detection of pathogens and biomarkers in whole blood without the need for culture, delivering results in hours rather than days. T2 Biosystems’ core mission is to provide clinicians with faster, actionable data to guide treatment decisions, particularly in the management of sepsis, bloodstream infections and other life‐threatening conditions.
The flagship product, the T2Dx® Instrument, serves as the platform for all T2 assays.
See Also
- Five stocks we like better than T2 Biosystems
- 3 Signs You May Want to Switch Financial Advisors
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
